Allergy, Asthma & Clinical Immunology

Casa
Argentina
Buenos Aires
Allergy, Asthma & Clinical Immunology

Scientific Information and News about Allergy, Asthma & Immunology worldwide

10/09/2026

A national clinical trial found that treating young children with an did not reduce the risk of severe and that can precede . https://medicalxpress.com/news/2026-09-bacterial-trial-early-asthma.html

10/09/2026

The first clues that a baby may develop or could be hiding in the microscopic organisms living on their . ://medicalxpress.com/news/2026-09-early-eczema-food-allergies-infants.html

10/09/2026

, including overweight or obesity, hypertension, dyslipidemia, and diabetes, were frequently reported among patients with (CRS), with prevalence generally comparable to global reference estimates. https://www.medscape.com/viewarticle/metabolic-conditions-common-chronic-rhinosinusitis-not-more-2026a1000xho

10/09/2026

Use of the -85 for the of in : a randomised, placebo-controlled trial. https://interasma.org/2026/09/10/use-of-the-bacterial-lysate-om-85-for-the-primary-prevention-of-wheezing-lower-respiratory-illness-in-preschool-children-a-randomised-placebo-controlled-trial/

10/09/2026

Beyond : Other in Environments. https://www.medscape.com/p11/beyond-tree-pollen-other-allergens-forest-environments-2026a1000xed

10/09/2026

up to 18 months after -19 – a longitudinal observational study. Open Access. https://link.springer.com/article/10.1186/s12931-026-03901-1

08/09/2026

linked to 20% fewer flare-ups and nearly 40% fewer attacks. The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at Congress in Barcelona, Spain. https://medicalxpress.com/news/2026-09-semaglutide-linked-copd-flare-ups.html

Dirección

Avenida Juan B. Alberdi 2756
Buenos Aires
C1406GSQ

Teléfono

+541146126273

Página web

https://patient.consultoriomovil.net/patient/web/alberdi2756/3574/dr-ivancevich-juan-carlos

Notificaciones

Sé el primero en enterarse y déjanos enviarle un correo electrónico cuando Allergy, Asthma & Clinical Immunology publique noticias y promociones. Su dirección de correo electrónico no se utilizará para ningún otro fin, y puede darse de baja en cualquier momento.